Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Oralee J. Varnado's publication output changed over time?
ScholarIQpublication output · 2015–2023
Output grew100% over the shown period — from 1 works in 2015 to 2 in 2023.
1
1
1
1
1
1
3
2
20152016201720192020202120222023
What are the most-cited papers on Oralee J. Varnado?
ScholarIQmost cited works
Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
Malaz Boustani, Isabella Pittman, Miao Yu, VT Thieu, Oralee J. Varnado, Rattan Juneja
Diabetes Obesity and Metabolism. 201647 CitationsOPEN ACCESS
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon
Vivian T. Thieu, Beth Mitchell, Oralee J. Varnado, Brian M. Frier
Diabetes Obesity and Metabolism. 201944 CitationsOPEN ACCESS
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
Todd J. Schwedt, Tina M. Oakes, James M. Martinez, Bert B. Vargas, Hitendra Pandey, Eric Pearlman, Diane R. Richardson, Oralee J. Varnado, Michael C. Meyer, Peter J. Goadsby
S2736361170. 202344 CitationsOPEN ACCESS
Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey
Jingwen Liu, Jeoffrey Bispham, Ludi Fan, Jiat Ling Poon, Allyson S. Hughes, Alicia H. McAuliffe‐Fogarty, Oralee J. Varnado, Beth Mitchell
BMJ Open. 202029 CitationsOPEN ACCESS
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
Matthew C. Riddle, Hertzel C. Gerstein, Denis Xavier, William C. Cushman, Lawrence A. Leiter, Peter Raubenheimer, Charles Atisso, Sohini Raha, Oralee J. Varnado, Маниге Кониг, Mark Lakshmanan, Edward Franek
The Journal of Clinical Endocrinology & Metabolism. 202128 CitationsOPEN ACCESS
Related on ScholarIQ
Eli Lilly (United States)
Institution
Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
Paper
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon
Paper
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
Paper
Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey
Paper
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
Paper